ImmuCell Corporation Line of Credit, Current
ImmuCell Corporation (ICCC) had Line of Credit, Current of $1.00 million as of 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities
us-gaap:LinesOfCreditCurrent · last filed 2023-08-10
- 2023-06-30: Line of Credit, Current $1.00M.
- 2023-03-31: Line of Credit, Current $1.00M.
- 2018-12-31: Line of Credit, Current $500.00K.
- 2017-06-30: Line of Credit, Current $500.00K.
| Period end | Line of Credit, Current |
|---|---|
| 2023-06-30 | $1.00M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $1.00M 10-Q · filed 2023-05-11 |
| 2018-12-31 | $500.00K 10-K · filed 2020-03-27 |
| 2017-06-30 | $500.00K 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |